compound semaglutide news Pharma's mess of its own making — greed, secrecy and weight-loss drugs Drugmakers battle pharmacies over compounded

Oct 9: In a relatively rare move, the FDA went against the recommendation of one of its advisory committees, rejecting a bid by Alnylam to expand Onpattro (patisiran)s label to cardiomyopathy of transthyretin-mediated amyloidosis

Scientific relevance depends on the research question, analytical model and laboratory controls determined by the qualified team carrying out the work

Duan, Y

For patients in particularly hot climates (such as Arizona, Texas, or Florida), consider using pharmacies that specialize in temperature-sensitive biologics and have robust cold-chain logistics

Break your fast with a balanced meal, not just coffee or a snack